via businessweek.com
AstraZeneca PLC on Friday agreed to pay $103 million to settle lawsuits that allege it inflated the price of its cancer drug Zoladex and its child asthma medication Pulmicort.
The lawsuits alleged that the British drug maker inflated the average wholesale price of the drugs, a benchmark rate used to determine how much the drugs cost for consumers, health plans and government programs.
No comments:
Post a Comment